All Updates

Earlier today, the New Jersey State Assembly Financial Institutions & Insurance Committee voted to move the Louisa Carmen Medical Debt Relief Act forward. A3861, sponsored by Assemblywoman Verlina Reynolds-Jackson, Assemblyman Wayne DeAngelo, Assemblyman Anthony Verrelli and Assemblyman Herb Conaway, will now head to the Assembly floor for further consideration.

Our 25 organizations, representing patients with serious health conditions and disabilities and their providers, applaud the Supreme Court’s unanimous ruling reversing the Fifth Circuit’s decision in Alliance for Hippocratic Medicine et al. v FDA et al, on the grounds that the plaintiffs don’t have standing in their challenge concerning the

TALLAHASSEE, Fla. – Gov. Ron DeSantis signed the Florida budget into law today, marking landmark investments in cancer priorities for the Sunshine State. The American Cancer Society Cancer Action Network (ACS CAN) applauds the funding that includes meaningful increases for many impactful initiatives. The budget triples the state’s investment

TALLAHASSEE, Fla. – Gov. Ron DeSantis signed the Florida budget into law today, marking landmark investments in cancer priorities for the Sunshine State. The American Cancer Society Cancer Action Network (ACS CAN) applauds the funding that includes meaningful increases for many impactful initiatives. The budget triples the state’s investment

Today, the House Insurance Committee passed legislation that would increase access to biomarker testing.

The Consumer Financial Protection Bureau (CFPB) released a proposed rule today to lessen the impact of medical debt on an individual’s credit.

Earlier this morning, House Bill 1754 was voted out of the Senate Banking & Insurance Committee. This legislation, which aims to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans when patients need it, now advances to the Senate floor for consideration.

This afternoon, the Pennsylvania State House passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.

With the summer adjournment of the 2024 legislative session here and no resolution on paid family and medical leave, the American Cancer Society Cancer Action Network (ACS CAN) and its advocates express their disappointment through a statement from Michael Davoli, Senior Government Relations Director for ACS CAN in New York: